Get the Stockscreener App
2.8075
10.80%
0.3075
Spero Therapeutics Inc Stock (SPRO) Forecast
The Spero Therapeutics Inc (SPRO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.4105, representing a +21.48% increase from the current price of $2.8075. The highest analyst price target is $4.9208, and the lowest is $1.9002.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SPRO Price Target
Average 7.888
(+180.96% Upside)
Is Spero Therapeutics Inc (SPRO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 87.94 | Sell |
| STOCH(9,6) | 83.36 | Sell |
| STOCHRSI(14) | 87.46 | Sell |
| MACD(12,26) | 0.4086 | Buy |
| ADX(14) | 35.19 | Buy |
| William %R | -6.1966 | Sell |
| CCI(14) | 235.83 | Buy |
Buy: 3
Sell: 4
Neutral: 0
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.3917
Buy
|
1.6777
Buy
|
| MA20 |
1.0071
Buy
|
1.2629
Buy
|
| MA50 |
0.8274
Buy
|
0.9601
Buy
|
| MA100 |
0.8298
Buy
|
0.9188
Buy
|
| MA200 |
1.0299
Buy
|
1.0256
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, SPRO could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 4 signaling Sell signals and 0 Neutral signals. This might be a good time to open fresh positions on SPRO, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 87.94 indicates that SPRO is overbought. This suggests that SPRO price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
- STOCH (Stochastic Oscillator): The STOCH value of 83.36 indicates that SPRO is oversold. This means that SPRO price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 87.46 indicates that SPRO is oversold. This suggests that SPRO price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 35.19 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 235.83 indicates that SPRO is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term SPRO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Spero Therapeutics Inc financial reports and earnings history, Spero Therapeutics Inc (SPRO) stock could reach $10.76 by 2030, $9.0416 by 2040 and $19.52 by 2050. See the projected annual prices until 2050 of the Spero Therapeutics Inc stock below:
- Spero Therapeutics Inc (SPRO) is expected to reach an average price of $3.4034 in 2035, with a high prediction of $3.7716 and a low estimate of $3.4434. This indicates an $21.23% rise from the last recorded price of $2.8075.
- Spero Therapeutics Inc (SPRO) stock is projected to chart a bullish course in 2040, with an average price target of $8.5399, representing an $204.18% surge from its current level. The forecast ranges from a conservative $8.6799 to a sky-high $9.0416.
- Our analysts predict Spero Therapeutics Inc (SPRO) to jump 480.66% by 2045, soaring from $16.35 to an average price of $16.30, potentially reaching $17.45. While $16.35 is the low estimate, the potential upside is significant.
- Spero Therapeutics Inc (SPRO) stock is expected to climb by 2050, reaching an average of $19.87, a $607.65% jump from its current level. However, a wide range of estimates exists, with high and low targets of $19.52 and $19.73, respectively, highlighting the market's uncertainty.
Spero Therapeutics Inc Stock (SPRO) Year by Year Forecast
Spero Therapeutics Inc Stock (SPRO) Price Forecast for 2025
Spero Therapeutics Inc Stock (SPRO) is expected to reach an average price of $3.1022 in 2025, with a high prediction of $6.2013 and a low estimate of $0.00301. This indicates an +10.50% rise from the last recorded price of $2.8075.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $4.2808 | $1.9002 | $4.9208 | +52.48% |
| August, 2025 | $4.0849 | $3.6843 | $5.4473 | +45.50% |
| September, 2025 | $4.259 | $2.7154 | $5.1883 | +51.70% |
| October, 2025 | $0.3266 | $0.1334 | $5.0095 | -88.37% |
| November, 2025 | $2.6607 | $0.3001 | $5.7001 | -5.23% |
| December, 2025 | $4.7784 | $2.5643 | $6.2013 | +70.20% |
Spero Therapeutics Inc Stock (SPRO) Price Forecast for 2026
The predicted value for Spero Therapeutics Inc (SPRO) in 2026 is set at an average of $10.03. Estimates vary from a peak of $15.64 to a trough of $4.4242, indicating an +257.38% surge from the present price of $2.8075.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $8.5325 | $4.4319 | $8.7425 | +203.92% |
| February, 2026 | $9.6366 | $8.036 | $11.38 | +243.24% |
| March, 2026 | $8.5207 | $7.8907 | $15.64 | +203.50% |
| April, 2026 | $12.78 | $6.1913 | $14.44 | +355.15% |
| May, 2026 | $8.2424 | $7.1254 | $12.93 | +193.59% |
| June, 2026 | $5.5865 | $5.106 | $8.696 | +98.99% |
| July, 2026 | $6.6042 | $4.4242 | $7.0871 | +135.23% |
| August, 2026 | $8.2283 | $5.8977 | $8.7483 | +193.08% |
| September, 2026 | $8.7359 | $6.4989 | $10.08 | +211.16% |
| October, 2026 | $7.32 | $6.1375 | $8.5795 | +160.73% |
| November, 2026 | $12.49 | $5.9271 | $12.52 | +345.03% |
| December, 2026 | $11.86 | $10.50 | $13.28 | +322.50% |
Spero Therapeutics Inc Stock (SPRO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Spero Therapeutics Inc (SPRO) is $6.2336, with a high forecast of $12.32 and a low forecast of $0.1483. This indicates an +122.03% increase from the last price of $2.8075.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $10.49 | $9.5859 | $12.32 | +273.50% |
| February, 2027 | $10.18 | $9.485 | $11.96 | +262.60% |
| March, 2027 | $7.4376 | $6.4876 | $10.66 | +164.92% |
| April, 2027 | $7.1818 | $5.6718 | $10.25 | +155.81% |
| May, 2027 | $4.7459 | $4.5659 | $7.0053 | +69.04% |
| June, 2027 | $2.8935 | $2.4964 | $5.0536 | +3.06% |
| July, 2027 | $3.1176 | $1.8606 | $3.897 | +11.05% |
| August, 2027 | $0.0317 | $0.1483 | $2.3547 | -98.87% |
| September, 2027 | $4.0406 | $0.7679 | $3.9106 | +43.92% |
| October, 2027 | $4.2087 | $4.0771 | $4.0965 | +49.91% |
| November, 2027 | $4.1878 | $4.213 | $4.2099 | +49.17% |
| December, 2027 | $4.0648 | $4.0948 | $4.1389 | +44.78% |
Spero Therapeutics Inc Stock (SPRO) Price Forecast for 2028
In 2028, Spero Therapeutics Inc (SPRO) is projected to reach an average price of $2.6691, with a high projection of $3.8762 and a low estimate of $1.4619. This indicates an -4.93% fall from the last price of $2.8075.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.984 | $3.8767 | $3.8762 | +41.90% |
| February, 2028 | $2.5766 | $2.7666 | $3.5236 | -8.23% |
| March, 2028 | $2.4489 | $2.4985 | $2.3938 | -12.77% |
| April, 2028 | $2.3548 | $2.4498 | $2.3454 | -16.12% |
| May, 2028 | $2.5172 | $2.3778 | $2.4072 | -10.34% |
| June, 2028 | $2.0931 | $2.1721 | $2.3337 | -25.45% |
| July, 2028 | $2.049 | $2.0625 | $2.041 | -27.02% |
| August, 2028 | $2.1913 | $2.1354 | $2.1684 | -21.95% |
| September, 2028 | $2.0272 | $2.1272 | $2.1443 | -27.79% |
| October, 2028 | $1.4531 | $1.6931 | $1.7537 | -48.24% |
| November, 2028 | $1.4155 | $1.5055 | $1.426 | -49.58% |
| December, 2028 | $1.6514 | $1.4619 | $1.5464 | -41.18% |
Spero Therapeutics Inc Stock (SPRO) Price Forecast for 2029
The 2029 price forecast for Spero Therapeutics Inc Stock (SPRO) is $4.7675 on average, with a high prediction of $9.53 and a low estimate of $0.00498. This represents an +69.81% increase from the previous price of $2.8075.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.3037 | $1.4027 | $1.5678 | -53.56% |
| February, 2029 | $1.5196 | $1.4002 | $1.4496 | -45.87% |
| March, 2029 | $1.3855 | $1.2326 | $1.2955 | -50.65% |
| April, 2029 | $1.4014 | $1.4184 | $1.3549 | -50.08% |
| May, 2029 | $1.2538 | $1.3238 | $1.3408 | -55.34% |
| June, 2029 | $1.0596 | $1.0896 | $1.1002 | -62.26% |
| July, 2029 | $0.6255 | $0.7655 | $0.8561 | -77.72% |
| August, 2029 | $0.4079 | $0.4179 | $0.5185 | -85.47% |
| September, 2029 | $0.2838 | $0.3438 | $0.3608 | -89.89% |
| October, 2029 | $0.1239 | $0.00968 | $0.2303 | -95.59% |
| November, 2029 | $0.092 | $0.0774 | $0.2509 | -96.72% |
| December, 2029 | $9.67 | $0.00498 | $9.53 | +244.43% |
Spero Therapeutics Inc Stock (SPRO) Price Forecast for 2030
Spero Therapeutics Inc Stock (SPRO) is expected to reach an average price of $10.65 in 2030, with a high forecast of $12.17 and a low forecast of $9.1342. This signifies an +279.49% surge from the last price of $2.8075.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $10.18 | $10.84 | $10.76 | +262.77% |
| February, 2030 | $11.21 | $10.88 | $10.10 | +299.16% |
| March, 2030 | $12.00 | $11.76 | $11.15 | +327.37% |
| April, 2030 | $11.48 | $11.54 | $11.75 | +308.91% |
| May, 2030 | $10.03 | $9.5389 | $10.74 | +257.43% |
| June, 2030 | $9.6466 | $10.22 | $9.8477 | +243.60% |
| July, 2030 | $9.3063 | $10.03 | $9.7285 | +231.48% |
| August, 2030 | $9.3731 | $9.1342 | $8.5431 | +233.86% |
| September, 2030 | $10.76 | $10.01 | $10.21 | +283.43% |
| October, 2030 | $10.51 | $10.33 | $10.26 | +274.34% |
| November, 2030 | $12.83 | $10.31 | $10.11 | +356.99% |
| December, 2030 | $11.74 | $11.65 | $12.17 | +318.28% |
1.76%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):